Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00407082 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants
A Phase 2 study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 2
- Development phase
- 278
- Enrollment target
NCT00407082 is a Phase 2 study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 278 participants.
The verdict
NCT00407082, a Phase 2 study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 278 participants
- Enrollment target
Study Summary
This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide (FA) intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare the safety and efficacy of two doses of fluocinolone acetonide.
Interventions
- DRUG fluocinolone acetonide intravitreal implant
- DRUG Fluocinolone acetonide 2.1mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2000-12 |
| Est. Completion | 2005-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00407082
The ClinicalTrials.gov registry entry for NCT00407082 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fluocinolone acetonide intravitreal implant is the first listed.
NCT00407082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00407082 about?
NCT00407082 is a clinical study titled "Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants". This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide (FA) intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare th...
What is the current status of trial NCT00407082?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 278 participants. The study started on 2000-12. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00407082?
The interventions under investigation include: fluocinolone acetonide intravitreal implant (DRUG), Fluocinolone acetonide 2.1mg (DRUG).
Who is sponsoring clinical trial NCT00407082?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.